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Abstract  
A novel cationic cyclometallated Ir(III) complex, namely [Ir(C^N-ppy-4-
CH=CHC6H4NEt2)2(N^N-bpy-CH=CHC6H4NEt2)] (ppy= 2-phenylpyridine; bpy= 2,2’-
bipyridine), was prepared and well characterized. Its good second-order NLO response, as 
determined in solution by the EFISH technique, and its interesting two-photon absorption 
activity, as measured by the Z-scan technique in the femtosecond case, make it a good 
candidate for application in photonics and biomedicine. 
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Introduction 
Coordination compounds with both luminescent and second-order nonlinear optical 
(NLO) properties are of great interest as multifunctional materials, as they may offer 
additional flexibility, when compared to organic NLO chromophores, by introducing new 
NLO active electronic charge-transfer transitions between the metal and the ligand, tuneable 
by virtue of the nature, oxidation state and coordination sphere of the metal centre [1,2]. 
Cyclometallating ligands are often incorporated in Ir(III) complexes for various applications 
such as in organic light-emitting diodes (OLEDs) [3], light-emitting electrochemical cells 
(LEECs) [4], and dye-sensitized solar cells (DSSCs) [5]. Whereas cyclometallated Ir(III) 
complexes have been intensively studied for their interesting luminescent properties, to our 
knowledge, only a few reports appeared in the literature on their second-order NLO properties 
[6, 7] or two-photon absorption (TPA) activity [8-11]. Yet, two-photon absorbing materials 
having large two-photon absorption cross-section (), especially in the near-infrared (NIR) 
region, are required for photodynamic therapy, bio-imaging, upconversion lasing and drug 
delivery [9] whereas the design of novel second-order NLO active compounds is crucial for 
many applications in the fields of optical communication and data processing [2]. Beeby and 
co-workers reported a series of iridium(III) acetylacetonate complexes, bearing two 
cyclometallated substituted 2-phenylpyridines, characterized by fair values of TPA cross 
sections (approximatively 20 GM) [10]. Another report concerning iridium complexes of a 
terpyridyl-stilbene system demonstrated TPA cross-sections in the range of 10-70 GM [11]. 
More recently, Das and co-workers reported the synthesis of cyclometallated iridium(III) 
complexes containing two cyclometallated unsubstituted 2-phenylpyridines and a 2,2’-
bipyridine bearing highly -delocalized substituents with TPA cross-sections in the range of 
45-196 GM in the femtosecond case [8c]. Besides, some of us reported that iridium(III) 
acetylacetonate complexes bearing two substituted cyclometallated 4-styryl-2-
phenylpyridines are characterized by a good second-order NLO response [7f], as determined 
by means of the Electric Field Induced Second Harmonic generation (EFISH) technique [12]. 
Remarkably, the simple luminescent cyclometallated Ir(III) complex [Ir(C^N-ppy-4-
CH=CHC6H4NEt2)2(acetylacetonate)] (ppy = 2-phenylpyridine) [13] shows a μβ1.907 = -550 x 
10-48 esu and is a useful tool for the preparation of NLO active polymeric films [7f]. These 
interesting results prompted us to investigate the effect of the substitution of the 
acetylacetonate ligand by a π-delocalized bipyridine incorporating electron-donor substituents 
on the second-order NLO response. Therefore, we prepared the novel cationic cyclometallated 
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3 
Ir(III) complex [Ir(C^N-ppy-4-CH=CHC6H4NEt2)2(N^N-bpy-CH=CHC6H4NEt2)] (5) 
(bpy=bipyridine; Figure 1) and studied its luminescent and NLO properties. Its second-order 
NLO response was measured in solution through the EFISH technique, working with an 
incident and non resonant wavelength of 1907 nm, whereas its two-photon absorption activity 
was evaluated by the Z-scan technique in the femtosecond case. 
 
 
 
 
 
Figure 1. Investigated cyclometallated Ir(III) complex (5) 
Material and methods 
Synthesis 
General comments 
All reagents were purchased from Sigma-Aldrich and were used without further purification. 
Reactions requiring anhydrous conditions were performed under nitrogen. 1H NMR spectra 
were recorded at 400 MHz on a Bruker AVANCE-400 instrument; chemical shifts (δ) are 
expressed in ppm relative to internal Me4Si as standard; signals were abbreviated as s, singlet; 
bs, broad singlet; d, doublet; t, triplet; q, quartet; m, multiplet. The UV-Vis spectra of the 
samples solution in dichloromethane were recorded by a Shimadzu UV-3150 spectrometer 
using 1 cm quartz cells.   
4-methyl-2-phenylpyridine (1). An excess of lithium (1.82 g, 272 mmol) was suspended in 
40 mL of Et2O. The suspension was cooled down to 0°C and bromobenzene (21.34 g, 136 
mmol) in 50 mL of Et2O was added dropwise during 20 minutes. The reaction mixture was 
stirred overnight at room temperature. The freshly-prepared phenyllithium was added 
dropwise to a solution of 4-picoline (3.16 g, 34 mmol) in 90 mL toluene. The reaction was 
stirred at 30°C for 24 hours, distilled water was added dropwise, the residue was extracted 
with CH2Cl2, washed with water, dried over MgSO4 and the solvent was removed under 
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reduced pressure. The product was purified by column chromatography (silica, n-
heptane:AcOEt=9:1) to afford 1 as an orange/brown solid (2.44 g). Yield: 42%. 1H-NMR 
(400 MHz, CDCl3) δ (ppm): 8.58 (1H, d, J = 5.0 Hz), 8.00 (2H, d, J = 7.2 Hz), 7.57 (1H, s), 
7.49 (2H, t, J = 7.4 Hz), 7.43 (1H, t, J = 7.2 Hz), 7.08 (1H, d, J = 4.9 Hz), 2.44 (3H, s). 
4-N,N-diethylminostyryl-2-phenylpyridine (2). 4-Methyl-2-phenylpyridine (500 mg, 2.96 
mmol), 4-N,N-diethylaminobenzaldehyde (620 mg, 3.5 mmol) and t-BuOK  (700 mg, 6.2 
mmol) were dissolved in DMF (20 mL). The reaction mixture was heated at reflux overnight, 
then CH2Cl2 (150 mL) was added. The organic phase was washed first with water and then 
with an aqueous solution of 1 M KOH, dried with MgSO4 and the solvent was removed under 
reduced pressure. The crude product was purified by column chromatography (silica, 
CH2Cl2:petroleum ether = 7:3) to obtain 2 as a yellow powder (546 mg). Yield: 56%. 1H 
NMR (400 MHz, CDCl3) δ (ppm): 8.61 (1H, d, J = 5.2 Hz), 8.06 (2H, d, J = 7.2 Hz), 7.75 
(1H, s) 7.51 (2H, t, J = 7.4 Hz), 7.45 (3H, d, J = 8.5 Hz), 7.30 (1H, d, J = 16.3 Hz), 7.26 (1H, 
m), 6.86 (1H, d, J = 16.2 Hz), 6.68 (2H, d, J = 8.8 Hz), 3.40 (4H, q, J = 7.1 Hz), 1.20 (6H, t, J 
= 7.0 Hz). 
[Ir(C^N-ppy-4-CH=CHC6H4NEt2)2Cl]2 (3). IrCl3  3H2O (165 mg, 0.55 mmol) and 2 (550 
mg, 1.66 mmol) were suspended in a mixture of 2-ethoxyethanol:H2O 3:1 (16 mL) in a 
Schlenk tube under inert atmosphere. The reaction mixture was heated at reflux for 24 h. The 
precipitate was decanted by centrifugation and the solid product was then washed 
successively with H2O, EtOH and Et2O. The solvent was removed with cannula to afford 3 as 
an orange powder (290 mg). Yield: 30%. 1H-NMR (400 MHz, CD2Cl2) δ (ppm): 9.12 (4H, d, 
J = 5.9 Hz), 7.94 (4H, s), 7.63 (4H, d, J = 7.1 Hz), 7.41 (12H, m), 7.04 (4H, d, J = 16 Hz), 
6.93 (4H, m), 6.83 (4H, t, J = 7.0 Hz), 6.64 (12H, m), 6.05 (4H, d, J = 8.0 Hz), 3.48 (16H, q, J 
= 6.8 Hz), 1.25 (24H, t, J = 6.8 Hz). 
4,4'-p-[(N,N-diethyl)aminostyryl]-2,2'-bipyridine (4). Diisopropylamine (607.1 mg, 6 
mmol) was dissolved in THF (2.5 mL) in a Schlenk tube and the mixture was cooled to 0°C. 
A n-BuLi solution (1.6 M in hexane, 3.75 mL, 6 mmol) was added slowly. After stirring one 
hour, the solution was cooled to -78°C and 4,4’-dimethyl-2,2’-bipyridine (501.1 mg, 2.72 
mmol) in THF (13 mL) was added dropwise and the mixture stirred at low temperature for 2 
hours. p-(N,N-diethyl)aminobenzaldehyde (957.1 mg, 5.4 mmol) was dissolved in 6 mL of 
THF (6 mL) and added slowly. The resulting mixture was stirred for one hour at low 
temperature and overnight at room temperature. After hydrolyzing with distilled water (12 
mL), the phases were separated, the organic phase was dried over MgSO4, filtered and the 
solvent was removed under reduced pressure. The dialcohol was dissolved in toluene (40 mL) 
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5 
in a round-bottomed flask and pyridinium p-toluenesulfonate (PPTS, 67.6 mg, 0.27mmol) 
was added. The mixture was heated at reflux for 4 hours. After cooling to room temperature, 
the solvent was removed under reduced pressure and dichloromethane (16 mL) was added. 
The mixture was washed with a saturated solution of NaHCO3. The precipitated bipyridine 
was filtered, abundantly washed first with H2O and then with Et2O to obtain 4 as an orange 
powder (970 mg). Yield: 71%. 1H-NMR (400 MHz, CD3Cl) δ (ppm): 8.63 (2H, d, J = 5.1 Hz), 
8.48 (2H, s), 7.47 (4H, d, J = 8.9 Hz), 7.42 (2H, d, J = 16.2 Hz), 7.36 (2H, dd, J = 5.3, 1.8 
Hz), 6.92 (2H, d, J = 16.2 Hz), 6.71 (4H, d, J = 8.9 Hz), 3.43 (8H, q, J = 7.1 Hz), 1.22 (12 H, 
t, J = 7.1 Hz). 
[Ir(C^N-ppy-4-CH=CHC6H4NEt2)2(N^N-bpy-CH=CHC6H4NEt2)][PF6] (5). A suspension 
of 3
 
(250 mg, 0.14 mmol), 4 (178 mg, 0.35 mmol) and AgPF6 (88 mg, 0.35 mmol) in 1,2-
dichloroethane (20 mL) was kept at reflux for 2 hours and stirred at room temperature for 16 
hours. The solvent was removed under reduced pressure leaving a residue which was washed 
with Et2O (3 x 20 mL). The compound was precipitated from Et2O/CH2Cl2 giving the desired 
complex (5) as a red solid after filtration (50 mg). Yield: 13%. 1H NMR (500 MHz, CD2Cl2) δ 
(ppm): 8.32 (2H, s), 7.93 (2H, s), 7.84 (2H, d, J = 5.7 Hz), 7.80 (2H, d, J = 7.4 Hz), 7.42 
(18H, m,), 7.08 (2H, t, J = 7.7 Hz), 7.02 (2H, d, J = 4.5 Hz), 6.95 (4H, m), 6.86 (2H, d, J = 
16.0 Hz), 6.68 (8H, dd, J = 16, 8.9 Hz), 6.46 (2H, d, J = 7.9 Hz), 3.41 (16H, m), 1.20 (24H, 
m). Elem. Anal. Calcd for C80H84F6IrN7P: C,71.19; H, 6.27; N, 8.30. Found: C, 71.65; H, 
6.28; N, 8.33. 
EFISH measurements 
EFISH measurements [12] were carried out at the Dipartimento di Chimica of the Università 
di Milano, in CH2Cl2 solutions at a concentration of 1 x 10–3 M, working with an incident 
non-resonant wavelength of 1.907 ȝm, obtained by Raman-shifting the fundamental 1.064 ȝm 
wavelength produced by a Q-switched, mode-locked Nd3+:YAG laser manufactured by 
Atalaser. The apparatus for the EFISH measurements is a prototype made by SOPRA 
(France). The reported ȝβEFISH values are the mean values of 16 successive measurements 
performed on the same sample. The sign of ȝβ is determined by comparison with the 
reference solvent (CH2Cl2). 
 
Two-photon absorption activity measurements 
All open-aperture Z-scan measurements [13] were performed at AIST in Osaka, for the 
solution of the complex 5 held in a 2-mm quartz cuvette.  The setup for the Z-scan 
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measurements were reported elsewhere [14]. A femtosecond, wavelength-tunable laser 
(optical parametric amplifier, SpectraPhysics TOPAS Prime) was employed as light source to 
obtain the spectrum.  Typical pulsewidth was 120 fs and the repetition rate was 1 kHz.  First, 
the outline of the TPA spectrum was measured at a single excitation power (0.4 mW, 
corresponding to the on-axis optical intensity at the focal point of 99-150 GW/cm2) by 
assuming that the observed open-aperture Z-scan signal originates from the TPA process 
(open dots in Fig. 4).  Then the assumption was confirmed and the precise value of the TPA 
cross section (σ(2)) were obtained by changing the excitation power (filled dots with 
experimental errors in Fig. 4).  Finally, the relative TPA spectrum (open dots) were 
superimposed the absolute TPA spectrum (filled dots). For all measurements, in-house 
standard compounds (MPPBT [15] in DMSO) was measured at the same condition and used 
for the spectral correction of σ(2). 
 
 
Results and Discussion 
The complex [Ir(C^N-ppy-4-CH=CHC6H4NEt2)2(N^N-bpy-CH=CHC6H4NEt2)][PF6] 
(5) was prepared as shown in Figure 2. 
 
Figure 2. (i) t-BuOK, DMF, 155°C, 15 h; (ii) IrCl33H2O, 2-ethoxyethanol/H2O, 100°C, 24 h; (iii) a) n-BuLi, 
iPr2NH, p-(N,N-diethyl)aminobenzaldehyde, THF, 0°C  -78°C  rt, 15 h; b) PPTS, toluene, 110°C, 4 h; (iv) 
AgPF6, 1,2-dichloroethane, 84°C, 2 h  rt, 15 h.   
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7 
 
The pro-ligand 4-(N,N-diethyl)aminostyryl-2-phenylpyridine (2) was readily prepared upon 
deprotonation of the methyl group of 4-methyl-2-phenylpyridine, obtained by reaction of 
phenyllithium with 4-picoline, followed by condensation with p-(N,N-
diethyl)aminobenzaldehyde, as previously reported [16]. Heating at reflux this pro-ligand 
with IrCl3  3H2O in a 2-ethoxyethanol:H2O 3:1 mixture for 24 h afforded the related ȝ-
dichloro-bridged cyclometallated iridium dimer intermediate (3) [16]. The ancillary ligand 
4,4'-p-[(N,N-diethyl)aminostyryl]-2,2'-bipyridine (4) was prepared like 2 but starting from 
4,4’-dimethyl-2,2’bipyridine [17]. The desired complex (5) was finally obtained by refluxing 
in 1,2-dichloroethane for 2 hours this -delocalized substituted bipyridine with the ȝ-
dichloro-bridged cyclometallated iridium dimer. It was obtained as a dark red powder and 
well characterized (see Material and methods). 
The absorption spectrum of complex 5 was registered both in dichloromethane and 
dimethyl sulfoxide (DMSO, Figure 3a) whereas the photophysical data are listed in Table 1. 
By analogy with other cationic iridium(III) complexes bearing two cyclometallated 
phenylpyridines and a bipyridine [6e], the absorption bands under 350 nm can reasonably be 
assigned to 1(-*) transitions of the styrylphenylpyridine and styrylbipyridine ligands, the 
intense band between 350 and 550 nm can be assigned to an Intra-Ligand Charge Transfer 
(ILCT) transition in which the pyridyl moiety acts as a π*-acceptor group hiding the (d(Ir) → 
π*(ppy/bpy)) MLCT band, while the weak band centered at 620 nm may be due to direct 
population of triplet charge transfer states [6e]. A pronounced solvatochromic behavior is 
observed going from DMSO to CH2Cl2, typical of electronic transitions with an appreciable 
degree of charge-transfer character; the blue shift of the band with increasing solvent polarity 
suggests a lower dipole moment in the excited state than in the ground state [18]. 
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The normalized photoluminescence (PL) spectra of 5 in degassed THF at 298 K and  at 77 K 
are shown in Figure 3b, and the data are summarized in Table 1. The novel complex is only 
very weakly emissive in fluid solution at room temperature (Figure 3b), because the radiative 
decay is quenched by the known competitive non-radiative trans-cis isomerization process of 
the C-C double bond, triggered by excitation with light before emission, of bipyridines linked 
to an Ir(III) center [6e, 19]. 
 
abs / nm 
( × 103 / M-1cm-1)a em/nm
b
 /µsb ȝβ1.907 /x10-48 esuc 
454 (7.54), 621 (0.59) 669, 736   57 
-960 
 
Table 1.  Photophysical data for complex 5. [a] In CH2Cl2 solution at 298 K; in DMSO: abs = 440 nm,  × 103 = 
5.37  M-1cm-1. [b] In THF at 77 K (exc = 460 nm). [c] In CH2Cl2 solution (103M); uncertainty in EFISH 
measurements is ±10% 
 
On the other hand, 5 is emissive at 77 K in THF, the luminescence spectrum is highly 
structured and the emission is located in the red region of the visible spectrum, as predicted 
upon incorporation of extended π-conjugated substituents in the ligands. With reference to 
previously reported Ir(III) complexes bearing two cyclometallated phenylpyridines and one 
bipyridine [6e], considering the highly structured spectrum and the long lifetime (57 ȝs), 
luminescence can be assigned to radiative decay from a triplet state predominantly localized 
on the styryl-substituted ligands, rather than from the MLCT state. In any case the 
Figure 3. a) Superposition of absorption spectra of complex 5 in DMSO (red) and CH2Cl2 (blue); b) 
Excitation spectrum at 77 K (blue line), emission spectrum at 298 K (black line) and emission spectrum at 
77 K (red line), all in a degassed 5x10-5 M THF solution of 5 (Ȝexc = 450 nm).  
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9 
participation of the metal in the emission is necessary to promote the population of the 
formally forbidden triplet emissive state.  
The quadratic hyperpolarizability of complex 5 was measured by the solution phase 
direct current EFISH generation method, which can provide direct information on the intrinsic 
molecular NLO properties through eq 1: 
 
Ȗ EFISH = (ȝȕȜ/5kT) + Ȗ(-2ω;ω,ω, 0)             (1) 
 
where ȝȕȜ/5kT is the dipolar orientational contribution and Ȗ(-2ω; ω, ω, 0) is the third-order 
polarizability corresponding to the mixing of two optical fields at ω and the dc poling field at 
ω=0. This latter term is often referred as the electronic cubic contribution to Ȗ EFISH, which is 
usually negligible. ȕȜ is the projection along the dipole moment (ȝ) axis of the vectorial 
component of the tensor of the quadratic hyperpolarizability at the incident wavelength Ȝ. All 
EFISH measurements
 
were carried out working in CH2Cl2 solutions at a concentration of 10
–3 
M, with a non resonant incident wavelength of 1.907 μm, obtained by Raman-shifting in a 
high pressure H2 of the fundamental 1.064 μm wavelength produced by a Q-switched, mode-
locked Nd
3+
:YAG laser.  
It turned out that complex 5 is characterized by a negative value of 1.907 (-960x10-48 esu, 
Table 1) in agreement with the observed solvatochromic behavior and with a negative value 
of Δȝeg (difference of the dipole moment in the excited and ground state) upon excitation [2]. 
It is worth pointing out that the absolute 1.907 value of complex 5 is almost twice that 
reported for related [Ir(C^N-ppy-4-CH=CHC6H4NEt2)2(acetylacetonate)] (ppy = 2-
phenylpyridine) [7e] suggesting that 4,4'-p-[(N,N-diethyl)aminostyryl]-2,2'-bipyridine is much 
better than acetylacetonate as ancillary ligand in this kind of cyclometallated Ir(III) complexes 
for second-order nonlinear optics.  
Complex 5 was then investigated for its two-photon absorption activity. It was 
dissolved in DMSO (0.55 mM) and studied with the z-scan technique in the femtosecond case. 
The TPA spectrum is shown in Figure 4. 
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Remarkably, the two-photon absorption cross-sections are quite high, in the range 100-250 
GM at 600-1000 nm. Contrarily to previously reported TPA active cationic iridium(III) 
complexes having two cyclometallated unsubstituted 2-phenylpyridines and a 2,2’-bipyridine 
bearing highly -delocalized substituents [8c], the complex investigated here has less 
extended substituents on the bipyridine but it bears them also on the 2-phenylpyridine ligands. 
The excellent correspondence of the observed TPA peak with the wavelength-doubled one-
photon absorption peak, as shown in Figure 4, suggests that the TPA peak mainly originates 
from the dipolar contribution [20] governed by asymmetric charge transfer, similar to the 
EFISH property.   In this way, the charge-transfer property and the extended π-conjugation 
over the whole molecule results in good TPA properties of 5 compared to the previously 
reported complexes of similar structures. Besides, it is worth pointing out that some 
iridium(III) complexes bearing two cyclometallated unsubstituted 2-phenylpyridines and a 2-
phenylimidazo[4,5-f][1,10]phenanthroline, characterized by two-photon absorption cross-
sections in the range 48.8-65.5 GM at 750 nm, were utilized as efficient agents for 
mitochondrial imaging and tracking in living cells under two-photon (750 nm) excitation [21]. 
Similarly, complex 5 can find application in biomedical research. 
 
 
Figure 4. The OPA (line) and TPA (dots) spectra of complex 5. 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
 
11 
Conclusion 
In conclusion, our work put in evidence how a careful choice of the coordination sphere of 
cyclometallated iridium(III) complexes can lead to high second-order nonlinear optical 
properties and two-photon absorption activity, correlated through the charge-transfer 
character of the complex. Substitution of acetylacetonate by a 4,4'-p-[(N,N-
diethyl)aminostyryl]-2,2'-bipyridine is a simple way to increase the second-order NLO 
response in this kind of cyclometallated Ir(III) complexes. In addition the use of simple -
delocalized donor substituents on both the cyclometallated 2-phenylpyridine and 2,2’-
bipyridine allows to reach high two-photon absorption sections in a wide range of 
wavelengths. Clearly the novel complex reported here has a great potential for application in 
photonics and biomedicine. 
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